INTRAVENOUS THERAPY
|
gtt/mL of given set 60 min/hr |
X | total volume/hr = gtt/min |
|
15 60 |
X 125 = |
1 4 |
X 125 = 32 gtt/min |
| Commonly Used Intravenous Fluids | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Transfusion with Blood or Blood Products
| Blood or Blood Product | Indications | Asessment: Side effects | Nursing Care Plan/Implementation |
|---|---|---|---|
| Whole blood |
|
|
|
| Red blood cells, packed |
|
See Whole Blood | See Whole Blood |
| Red blood cells, frozen |
|
|
See Whole Blood |
| White blood cells (leukocytes) | Currently being used in severe leukopenia with infection (research still being done) |
|
|
| Platelet concentrate |
|
|
Monitor temperature |
| See Single-donor fresh plasma |
|
|
Use sterile, pyrogen-free filters |
| Plasma removed from whole blood (up to 5 days after expiration date, which is 21 days) |
|
See Single-donor fresh plasma | See Single-donor fresh plasma |
| Freeze-dried plasma | See Plasma removed from whole blood | Single-donor fresh-frozen plasma |
|
| Cryoprecipitate concentrate (factor VIII—antihemophilic factor) |
For hemophilia:
|
Rare | 0.55 mL of cryoprecipitate concentrate has same effect on serum level as 1600 mL of fresh-frozen plasma |
| Factors II, VII, IX, and X compiled | Specific deficiencies | HepatitisCommercially prepared | Commercially prepared |
| Fibrinogen (factor I) | Fibrinogen deficiency | Increased risk of hepatitis because the hepatitis virus combines with fibrinogen |
|
| Albumin or salt-poor albumin |
|
None; these are heat-treated products | Commercially prepared |
| Dextran | Hypovolemic shock |
|
Commercially prepared |
| Complications of IV Therapy | |||
|---|---|---|---|
| Assesment | |||
| Complication | Subjective Data | Objective Data | Nursing Care Plan/Implementation |
|
Infiltration-fluid infusing into surrounding tissue rather than into vessel
|
Pain around needle insertion
|
|
|
|
Thrombophlebitis
-inflammatory changes in vessel;
thromboemboli
-the development of venous clots within the inflamed vessel
|
Pain along the vein
|
Redness, swelling around affected area (red line)
|
|
|
Pyrogenic reaction
-contami-
nated equipment/solution
|
|
|
|
|
Fluid overload
-excessive amount of fluid infused; infants/elderly at risk
|
|
|
|
|
Air emboli
-air in circulatory system
|
Loss of consciousness
|
|
|
|
Nerve damage
-improper position of limb during infusion or
tying
limb down too tight during infusion-damage to nerve
|
Numbness: fingers, hands
|
Unusual position for limb
|
|
|
Pulmonary embolism-
blood clot enters pulmonary circulation and obstructs pulmonary artery
|
Dyspnea
|
|
|